Immunitybio Inc (IBRX) — Net Asset Quality Index
Immunitybio Inc (IBRX) has a Net Asset Quality Index of -9.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $518.99 Million minus total liabilities of $569.82 Million yields net assets of $-50.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Immunitybio Inc debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Immunitybio Inc Net Asset Quality Index Over Time (2013–2024)
This chart shows how Immunitybio Inc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at -9.8%, representing net assets of $-50.83 Million against total assets of $518.99 Million USD. For live market cap and overall valuation, see IBRX stock market capitalisation.
Annual Net Asset Quality Index for Immunitybio Inc (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Immunitybio Inc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Immunitybio Inc (IBRX) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -127.5% | $-488.13 Million | $382.93 Million | $871.06 Million | ▼ -11.3 pp |
| 2023 | -116.2% | $-585.94 Million | $504.45 Million | $1.09 Billion | ▲ +8.0 pp |
| 2022 | -124.1% | $-449.82 Million | $362.36 Million | $812.18 Million | ▼ -72.1 pp |
| 2021 | -52.0% | $-243.91 Million | $468.91 Million | $712.82 Million | ▲ +1.5 pp |
| 2020 | -53.5% | $-118.49 Million | $221.38 Million | $339.87 Million | ▼ -137.8 pp |
| 2019 | 84.3% | $120.68 Million | $143.12 Million | $22.44 Million | ▲ +4.1 pp |
| 2018 | 80.2% | $146.01 Million | $181.95 Million | $35.94 Million | ▼ -7.1 pp |
| 2017 | 87.4% | $218.84 Million | $250.44 Million | $31.60 Million | ▼ -5.0 pp |
| 2016 | 92.4% | $293.42 Million | $317.50 Million | $24.08 Million | ▼ -4.6 pp |
| 2015 | 97.0% | $356.00 Million | $366.85 Million | $10.85 Million | ▲ +1.0 pp |
| 2014 | 96.0% | $58.42 Million | $60.83 Million | $2.40 Million | ▲ +233.7 pp |
| 2013 | -137.7% | $-2.90 Million | $2.10 Million | $5.00 Million | — |